Cargando…

RCAN1-mediated calcineurin inhibition as a target for cancer therapy

Cancer is the leading cause of mortality worldwide. Regulator of calcineurin 1 (RCAN1), as a patent endogenous inhibitor of calcineurin, plays crucial roles in the pathogenesis of cancers. Except for hypopharyngeal and laryngopharynx cancer, high expression of RCAN1 inhibits tumor progression. Molec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lao, Mengyi, Zhang, Xiaozhen, Yang, Hanshen, Bai, Xueli, Liang, Tingbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Mini-Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206313/ https://www.ncbi.nlm.nih.gov/pubmed/35717152 http://dx.doi.org/10.1186/s10020-022-00492-7

Ejemplares similares

Regulator of calcineurin 1 gene isoform 4 in pancreatic ductal adenocarcinoma regulates the progression of tumor cells
por: Lao, Mengyi, et al.
Publicado: (2021)

The structure of the RCAN1:CN complex explains the inhibition of and substrate recruitment by calcineurin
por: Li, Yang, et al.
Publicado: (2020)

RCAN1 in cardiovascular diseases: molecular mechanisms and a potential therapeutic target
por: Wang, Shuai, et al.
Publicado: (2020)

Combination cancer immunotherapy targeting TNFR2 and PD-1/PD-L1 signaling reduces immunosuppressive effects in the microenvironment of pancreatic tumors
por: Zhang, Xiaozhen, et al.
Publicado: (2022)

Regulator of Calcineurin (RCAN): Beyond Down Syndrome Critical Region
por: Lee, Sun-Kyung, et al.
Publicado: (2020)

RCAN1.4 attenuates renal fibrosis through inhibiting calcineurin-mediated nuclear translocation of NFAT2
por: Zhang, Jianjian, et al.
Publicado: (2021)

Targeting ubiquitin-specific protease 8 sensitizes anti-programmed death-ligand 1 immunotherapy of pancreatic cancer
por: Yang, Hanshen, et al.
Publicado: (2022)

NEK2 inhibition triggers anti-pancreatic cancer immunity by targeting PD-L1
por: Zhang, Xiaozhen, et al.
Publicado: (2021)

The regulator of calcineurin (RCAN1) an important factor involved in atherosclerosis and cardiovascular diseases development
por: Torac, E, et al.
Publicado: (2014)

Targeting MFAP5 in cancer-associated fibroblasts sensitizes pancreatic cancer to PD-L1-based immunochemotherapy via remodeling the matrix
por: Duan, Yi, et al.
Publicado: (2023)

O-GlcNAcylation: an important post-translational modification and a potential therapeutic target for cancer therapy
por: Lu, Qingsong, et al.
Publicado: (2022)

The RCAN1.4-calcineurin/NFAT signaling pathway is essential for hypoxic adaption of intervertebral discs
por: Huang, Bao, et al.
Publicado: (2020)

Integrative analysis identified two subtypes and a taurine-related signature to predict the prognosis and efficacy of immunotherapy in hepatocellular carcinoma
por: Lu, Qingsong, et al.
Publicado: (2023)

Regulator of calcineurin 1 (Rcan1) has a protective role in brain ischemia/reperfusion injury
por: Sobrado, Mónica, et al.
Publicado: (2012)

Cynanchi atrati and Its Phenolic Constituent Sinapic Acid Target Regulator of Calcineurin 1 (RCAN1) to Control Skin Inflammation
por: Kim, Seon Sook, et al.
Publicado: (2022)

Allele-Specific Phenotype Suggests a Possible Stimulatory Activity of RCAN-1 on Calcineurin in Caenorhabditis elegans
por: Li, Weixun, et al.
Publicado: (2016)

RCAN1.4 suppresses the osteosarcoma growth and metastasis via interfering with the calcineurin/NFAT signaling pathway
por: Huang, Bao, et al.
Publicado: (2021)

Targeting TNFR2: A Novel Breakthrough in the Treatment of Cancer
por: Li, Muchun, et al.
Publicado: (2022)

Eating self for not be eaten: Pancreatic cancer suppresses self-immunogenicity by autophagy-mediated MHC-I degradation
por: Huang, Xing, et al.
Publicado: (2020)

Covalent NEDD8 Conjugation Increases RCAN1 Protein Stability and Potentiates Its Inhibitory Action on Calcineurin
por: Noh, Eun Hye, et al.
Publicado: (2012)

The regulator of calcineurin 1 (RCAN1) inhibits nuclear factor kappaB signaling pathway and suppresses human malignant glioma cells growth
por: Chen, Xin, et al.
Publicado: (2017)

Growth hormone increases regulator of calcineurin 1-4 (Rcan1-4) mRNA through c-JUN in rat liver
por: Nakata, Tomoko, et al.
Publicado: (2020)

Methylation of RCAN1.4 mediated by DNMT1 and DNMT3b enhances hepatic stellate cell activation and liver fibrogenesis through Calcineurin/NFAT3 signaling
por: Pan, Xue-yin, et al.
Publicado: (2019)

Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy
por: Ying, Honggang, et al.
Publicado: (2022)

RCAN1 Inhibits BACE2 Turnover by Attenuating Proteasome-Mediated BACE2 Degradation
por: Qiu, Kaixin, et al.
Publicado: (2020)

VEGF Stimulates RCAN1.4 Expression in Endothelial Cells via a Pathway Requiring Ca(2+)/Calcineurin and Protein Kinase C-δ
por: Holmes, Katherine, et al.
Publicado: (2010)

Targeting the HGF/MET Axis in Cancer Therapy: Challenges in Resistance and Opportunities for Improvement
por: Huang, Xing, et al.
Publicado: (2020)

Combinational therapy targeting the MET‐mTOR‐ROS loop disrupts mitochondrial autoregulatory machinery of liver cancer
por: Huang, Xing, et al.
Publicado: (2020)

Spatiotemporal expression of RCAN1 and its isoform RCAN1-4 in the mouse hippocampus after pilocarpine-induced status epilepticus
por: Cho, Kyung-Ok, et al.
Publicado: (2020)

RCAN1 in the inverse association between Alzheimer’s disease and cancer
por: Fu, Qiang, et al.
Publicado: (2017)

The RCAN1 inhibits NF-κB and suppresses lymphoma growth in mice
por: Liu, C, et al.
Publicado: (2015)

Adjuvant therapy with gemcitabine and stereotactic body radiation therapy versus gemcitabine alone for resected stage II pancreatic cancer: a prospective, randomized, open-label, single center trial
por: Ma, Tao, et al.
Publicado: (2022)

RCAN1 Is an Important Mediator of Glucocorticoid-Induced Apoptosis in Human Leukemic Cells
por: Nagao, Kazuaki, et al.
Publicado: (2012)

NGF Upregulates the Plasminogen Activation Inhibitor-1 in Neurons via the Calcineurin/NFAT Pathway and the Down Syndrome-Related Proteins DYRK1A and RCAN1 Attenuate This Effect
por: Stefos, Georgios C., et al.
Publicado: (2013)

A major role for RCAN1 in atherosclerosis progression
por: Méndez-Barbero, Nerea, et al.
Publicado: (2013)

Rcan1 negatively regulates FcεRI-mediated signaling and mast cell function
por: Yang, Yong Jun, et al.
Publicado: (2009)

mir-182-5p Regulates Cell Growth of Liver Cancer via Targeting RCAN1
por: Zheng, Jianxing, et al.
Publicado: (2021)

RCAN1.4 mediates high glucose-induced matrix production by stimulating mitochondrial fission in mesangial cells
por: Chen, Hong-Min, et al.
Publicado: (2020)

Reviving the role of MET in liver cancer therapy and vaccination: an autophagic perspective
por: Huang, Xing, et al.
Publicado: (2020)

RCAN1C is differentially expressed in T helper cell subsets
por: Sieber, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3l2tajicp2iqgnkevu5ec4v4v0